Compare Amphastar Pharmaceuticals Inc (AMPH) vs Newegg Commerce Inc (NEGG) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

NEGG trades at $14.15, down 4.2% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $4.88M in 2025, though revenue was $1.44B and the net margin improved to -0.34%. Recent news highlights AI shopping features and sales events, while cash flow trends show operational challenges but financing support.

The outlook remains cautious; while valuation ratios like P/S of 0.21 appear low, profitability is weak and cash burn persists. Risks include competitive pressures and execution hurdles, but a sole analyst rates it Buy. Investors should weigh cost controls against sustained losses before considering a position.